Overview
Lexeo Therapeutics, Inc. is a publicly traded company headquartered in New York City [1]. The company is listed on the Nasdaq exchange under the ticker symbol LXEO [2]. According to the Securities and Exchange Commission, Lexeo operates in the biological products industry, excluding diagnostic substances [3]. In its most recent annual report, the company reported revenue of $654,000 for the year ending December 31, 2022, and held total assets of $268.7 million [4].
Business address: 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010. [1]
Financials
Reported revenue of $654,000 for the year ending 2022-12-31 and total assets of $268.7 million in its most recent annual report to the SEC. [4]
Something wrong or missing? Send an update. Fixed within 24 hours.